Merck takes Austria’s Keytruda price transparency battle to top court as journalists fight for information
The case stems from ICIJ’s Cancer Calculus investigation into the world's best-selling drug’s sky-high price and its global consequences.
Read the full articleYou might also wanna read
How a 25-Cent Cancer Pill Became a Hundred-Billion-Dollar Business
The story you just read was made possible by our readers. We hope it inspires you to support ProPublica, so we can continue producing invest
Trump’s drug price crusade puts Europe on guard
UK has given in to pharma industry lobbying but some EU member states promise to stand firm

STAT+: Compass says depression drug has long-lasting benefits
Vertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout
ROUNDUP: Bayer sichert sich 3 Milliarden Euro durch Pharma-Deal mit Apollo
Leverkusen (dpa-AFX) - Der durch US-Glyphosatklagen von hohen Schulden belastete Pharma- und Agrarchemiekonzern Bayer verschafft sich durch
A Cancer Patient and Reporter Investigates Why Revlimid Costs as Much as an iPhone Per Pill
When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high dru
ProPublica Investigation Reveals How Drugmaker's Price Hikes Made a $0.25 Pill Cost Nearly $1,000
Podcast Episode · Paper Trail · June 11 · 41m

Comments
Sign in to join the conversation.
No comments yet. Be the first.